HO CHI MINH CITY, Vietnam, March 22, 2018 -- Advancements in natural feed additives will help transform the poultry industry by providing a proven and reliable alternative to antibiotic growth promoters (AGPs) for improved performance and reduced mortality, according to Dr. Sim of Amlan International, a global leader in the development of innovative solutions to improve the health and productivity in livestock. Dr. Sim addressed producers, livestock veterinarians and industry leaders last week at ILDEX Vietnam, the biennial International Livestock, Dairy, Meat Processing and Aquaculture Exposition in Ho Chi Minh City.
|
|||||
Dr. Maximillian Sim, DVM, Amlan’s Southeast Asia Commercial and Technical Consultant, was a featured technical speaker at the conference, where he made the well-received presentation, “Varium™: Your Solution to Sustainability and Profitability in Antibiotic-Free Poultry Production.”
“Poultry producers worldwide lose $6 billion annually due to disease in their flocks. The reduction and elimination of AGPs in poultry diets has led to increased intestinal health challenges and a higher incidence of diseases such as necrotic enteritis, leading to significant economic losses for producers,” Dr. Sim stated. “A series of studies has shown that Varium provides benefits for poultry producers in the form of increased weight gain, reduced mortality and improved feed conversion – leading to stronger economic performance.”
In 2017, Amlan launched both of its newest growth promotion products in Vietnam, Varium for poultry and NeoPrime™ for post-weaning piglets, at an event they hosted for global industry leaders and targeted regional customers.
“Amlan is receiving positive feedback from Varium customers in Vietnam, one of the fastest-growing economies in the world, where changing dietary habits and rising incomes are resulting in dramatic increases in meat consumption,” says Dr. Ron Cravens, MS, DVM, President, Amlan International, a Nevada company. “Our growing portfolio of feed additive solutions is helping global producers meet the increasing demand for meat protein while also enabling them to maximize revenue and profit.”
To meet the demand, producers and nutritionists are looking for viable, drug-free alternatives to support intestinal health and improve performance. Natural, formulated feed additives such as Varium can provide an effective way to enhance performance with or without the inclusion of antibiotics.
Dr. Sim’s presentation at ILDEX focused on Varium research results and the implications for the poultry industry. He has 13 years of experience working in the animal health industry, providing field technical services and market development of nutraceutical products in Asia.
For more information about Amlan’s portfolio of intestinal health products, visit Amlan.com.
About Amlan International
Oil-Dri Corporation of America (NYSE:ODC), a Delaware corporation doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted at its laboratory campus in Vernon Hills, Illinois. In 2017, the company added the Richard M. Jaffee Laboratory for Applied Microbiology to the campus.
Amlan International sells animal health products outside of the United States, and product availability may vary by country. Product-associated claims do not constitute medical claims and may differ based on government requirements. The information contained herein is based on Amlan’s research and you should conduct your own tests to determine the suitability of Amlan’s products for your specific purposes. “Amlan,” “Varium” and “NeoPrime” are trademarks of Oil-Dri Corporation of America.
Reagan B. Culbertson
Media Contact
[email protected]
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/4c93b89e-8469-45f4-80aa-a6def38e97dc


Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



